Pharming presented what were described as strong quarterly figures on Tuesday, about one month after chief financial officer Kenneth Lynard and chief operating officer Leverne Marsh took over from unexpectedly departed chief executive Fabrice Chouraqui. The new leadership duo said the biotech company’s strategy remains unchanged.